Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

February 2025; Volume 45,Issue 2

Review

  • Open Access
    The Impact of AI-driven Remote Patient Monitoring on Cancer Care: A Systematic Review
    FAYHA AZIZ, DILETTA BIANCHINI, DAVID B. OLAWADE and STERGIOS BOUSSIOS
    Anticancer Research February 2025, 45 (2) 407-418; DOI: https://doi.org/10.21873/anticanres.17430

Experimental Studies

  • Open Access
    Noncancerous Exosomes Establish a Growth Promoting Paracrine Effect on Triple Negative Breast Cancer Cells
    LETITIA A. YEARBY, MANASA KOTINA, AFIA OHEMENG, BIPIKA BANJARA, MOUNIKA PAMUKUNTLA, PAIGE ROBERTS, JASMINE JOHNSON, KAITLYN PERKINS, JOSIAH OCHIENG, JILLIAN L. POPE, SYREETA L. TILGHMAN and KITANI PARKER LEMIEUX
    Anticancer Research February 2025, 45 (2) 419-431; DOI: https://doi.org/10.21873/anticanres.17431
  • Open Access
    Acyclic Retinoid Inhibits the EGFR/AKT Signaling Pathway and Cancels Cisplatin-resistant Cell Characteristics
    MAKITO MOTOYAMA, RYOTA SHIGEFUKU, NORIYOSHI TANAKA, MITSUAKI NISHIZAWA, KEIGO OSHIO, YOSHITOMO SUHARA and ICHIRO YAJIMA
    Anticancer Research February 2025, 45 (2) 433-443; DOI: https://doi.org/10.21873/anticanres.17432
  • Open Access
    Correlation of HLA-A and HLA-B/C Expression With ESR1 Expression in Patients With Metastatic Breast Cancer as a Potential Prognosticator of Favorable Distant Disease-free Survival
    LUKAS GOERDT, ALEKSANDRA STEFANOVIC, RALPH WIRTZ, UROS KARIC, THOMAS M. DEUTSCH, MAXIMILIAN KOHLER, ANDREAS SCHNEEWEISS, MARC SÜTTERLIN, STEFAN STEFANOVIC, JAN HOFMANN and MARKUS WALLWIENER
    Anticancer Research February 2025, 45 (2) 445-450; DOI: https://doi.org/10.21873/anticanres.17433
  • Open Access
    Recombinant Methioninase (rMETase) Synergistically Sensitizes Ivermectin-resistant MCF-7 Breast Cancer Cells 9.9 Fold to Low-dose Ivermectin
    SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, CHIHIRO HOZUMI, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN
    Anticancer Research February 2025, 45 (2) 451-455; DOI: https://doi.org/10.21873/anticanres.17434
  • You have access
    Synthesis of Polymethoxylated 3-Styrylflavones and their Antiproliferative Activity in HL60 Cells
    ARISA TSUTSUMI, SATORU KAWAII and YUKO YOSHIZAWA
    Anticancer Research February 2025, 45 (2) 457-464; DOI: https://doi.org/10.21873/anticanres.17435
  • Open Access
    Association of Matrix Metalloproteinase-1 Promoter Genotypes With Endometriosis Risk
    PO-CHUEN SHIEH, HOU-YU SHIH, CHIN-LIANG CHUANG, CHIA-WEN TSAI, WEN-SHIN CHANG, MENG-GI BAU, YUN-CHI WANG, TE-CHUN HSIA, DA-TIAN BAU and JAI-SING YANG
    Anticancer Research February 2025, 45 (2) 465-471; DOI: https://doi.org/10.21873/anticanres.17436
  • You have access
    MiR-5586-5p Suppresses Hypoxia-induced Angiogenesis Through Multiple Targeting of HIF-1α, HBEGF and ADAM17 in Breast Cancer
    DONGJO SHIN, JE-OK YOO, JAE-HOON JEONG and YOUNG-HOON HAN
    Anticancer Research February 2025, 45 (2) 473-489; DOI: https://doi.org/10.21873/anticanres.17437
  • You have access
    Adjusting Treatment Strategies Using Circulating Tumor Cells: Preliminary Results on Metastatic Colorectal Cancer
    JOACHIM DREVS, MANDEEP SINGH MALHOTRA, HUSEYIN SAHINBAS, AGGELOS ILIOPOULOS, GEORGE BEIS, PANAGIOTIS APOSTOLOU and IOANNIS PAPASOTIRIOU
    Anticancer Research February 2025, 45 (2) 491-502; DOI: https://doi.org/10.21873/anticanres.17438
  • Open Access
    Anti-tumor Effects of Erlotinib via Thymidylate Synthase Down-regulation in Pancreatic Cancer Cells
    SATOSHI TABUCHI, TETSURO TOMINAGA, TOMOSHI TSUCHIYA, RYOICHIRO DOI, JYUNICHI ARAI, TAKASHI NONAKA, TAKURO MIYAZAKI, TATSUO INAMINE, KAZUHIRO TSUKAMOTO and KEITARO MATSUMOTO
    Anticancer Research February 2025, 45 (2) 503-510; DOI: https://doi.org/10.21873/anticanres.17439
  • Open Access
    Pterostilbene Suppressed Cell Viability, Induced Apoptosis and Autophagy of Cisplatin-resistant Gastric Cancer Cells
    CHIEN-JUNG HUANG, PO-CHUEN SHIEH, JAI-SING YANG, YI-CHIA LI, YU-JEN CHIU, DA-TIAN BAU and CHIH-HSIN HUNG
    Anticancer Research February 2025, 45 (2) 511-523; DOI: https://doi.org/10.21873/anticanres.17440
  • You have access
    Immunosuppressive State May Lead to Brain Metastases in Lung Squamous Cell Carcinoma: Gene Expression and Immunohistochemical Analysis
    YOUNG WHA KOH, JAE-HO HAN, SEOKJIN HAAM and HYUN WOO LEE
    Anticancer Research February 2025, 45 (2) 525-534; DOI: https://doi.org/10.21873/anticanres.17441
  • You have access
    A New PD-L1 Nanobody Enhances Cell Death in Lung Cancer In Vitro and In Vivo
    XIAO-TONG TAN, SHI-WEI HUANG, YU-CHUAN LIN, FANG-YU LIN, DER-YANG CHO and SHAO-CHIH CHIU
    Anticancer Research February 2025, 45 (2) 535-547; DOI: https://doi.org/10.21873/anticanres.17442
  • You have access
    PRPF4 Knockdown Suppresses Glioblastoma Progression via the p38 MAPK and ERK Signaling Pathways
    WANSOO KIM, SONG PARK, SE-HYEON HAN, HEE-YEON KIM, SEOUNG-WOO LEE, DAEHWAN KIM, SOYOUNG JANG, JIN-KYU PARK, JEE EUN HAN, CHOONOK KIM, JAELIM CHO, ETHAN SEAH, JIYEON LEE, ZAE YOUNG RYOO and SEONG-KYOON CHOI
    Anticancer Research February 2025, 45 (2) 549-564; DOI: https://doi.org/10.21873/anticanres.17443
  • You have access
    Camptothecin Triggers Apoptosis in Human and Mouse Drug-resistant Glioblastoma Cells via ROS-mediated Activation of the p53-p21-CD1/CDK2-E2F1-Bcl-xL Signaling Axis
    GONG-JHE WU, JUI-TAI CHEN, YIH-GIUN CHERNG, CHIEN-JU LIN, SHING-HWA LIU and RUEI-MING CHEN
    Anticancer Research February 2025, 45 (2) 565-577; DOI: https://doi.org/10.21873/anticanres.17444
  • You have access
    Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling
    HASAYA DOKDUANG, APIWAT JARERNRAT, ATTAPOL TITAPUN, SIRINYA SITTHIRAK, SUREERAT PADTHAISONG, YINGPINYAPT KITTIRAT, SAKKARN SANGKAMANON, PRAKASIT SA-NGIAMWIBOOL, ARPORN WANGWIWATSIN, PORAMATE KLANRIT, NISANA NAMWAT, APINYA JUSAKUL, YOSHINORI MURAKAMI and WATCHARIN LOILOME
    Anticancer Research February 2025, 45 (2) 579-592; DOI: https://doi.org/10.21873/anticanres.17445
  • You have access
    Computational Exploration of a Diverse Flavonoid Library for Targeted Allosteric Inhibition of AKT1 in Cancer Therapy
    MOHD REHAN, ISHFAQ A. SHEIKH, MOHD SUHAIL, SHAMS TABREZ and SHAZI SHAKIL
    Anticancer Research February 2025, 45 (2) 593-604; DOI: https://doi.org/10.21873/anticanres.17446

Clinical Studies

  • Open Access
    Paired Comparison of Whole Genome Sequencing and Comprehensive Targeted Sequencing of Pancreatic Cancer Tissue
    THEA AMALIE HVIDTFELDT, TIM SVENSTRUP POULSEN, INNA MARKOVNA CHEN, LOUISE LAURBERG KLARSKOV and ESTRID HØGDALL
    Anticancer Research February 2025, 45 (2) 605-612; DOI: https://doi.org/10.21873/anticanres.17447
  • Open Access
    Unusual Presentation of Advanced Urothelial Cancer in a Young Patient
    DANIELA GUEVARA, NARA SHIN, ALEXANDRA BOIKO, IVAN VALIEV, AHMED G. ELSAEED, JUAN MIGUEL MOSQUERA, MAJD AL ASSAAD, JYOTHI MANOHAR, MICHAEL SIGOUROS, ALISA ZAICHIKOVA, VICTORIA FOMCHENKOVA, LEYSAN YUNUSOVA, SOFIA SMIRNOVA, OLIVIER ELEMENTO, DAVID NANUS and CORA N. STERNBERG
    Anticancer Research February 2025, 45 (2) 613-618; DOI: https://doi.org/10.21873/anticanres.17448
  • Open Access
    Mesonephric Adenocarcinoma in a Young Male Patient
    DANIELA GUEVARA, NARA SHIN, ALEXANDRA BOIKO, IVAN VALIEV, AHMED G. ELSAEED, JUAN MIGUEL MOSQUERA, MAJD AL ASSAAD, JYOTHI MANOHAR, MICHAEL SIGOUROS, ALISA ZAICHIKOVA, VICTORIA FOMCHENKOVA, LEYSAN YUNUSOVA, SOFIA SMIRNOVA, OLIVIER ELEMENTO, JONES NAUSEEF and CORA N. STERNBERG
    Anticancer Research February 2025, 45 (2) 619-623; DOI: https://doi.org/10.21873/anticanres.17449
  • Open Access
    Cyclin E Expression and p16 Loss Are Strong Prognostic Biomarkers in Primary Invasive Cutaneous Melanoma
    IOANNIS G. GKIONIS, MARIA TZARDI, ATHANASIOS ALEGAKIS, GALATEIA DATSERI, ELENI MOUSTOU, GEORGIOS SARIDAKIS, DIMOSTHENIS MICHELAKIS, SABINE KRUGER-KRASAGAKIS, KONSTANTINOS KRASAGAKIS and EELCO DE BREE
    Anticancer Research February 2025, 45 (2) 625-637; DOI: https://doi.org/10.21873/anticanres.17450
  • Open Access
    Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases
    GAKU YAMAMICHI, TAIGO KATO, AKIHIRO YOSHIMURA, MASARU TANI, YUKI HORIBE, YUTONG LIU, NESRINE SASSI, YOHEI OKUDA, TOSHIKI OKA, TOSHIHIRO UEMURA, AKINARU YAMAMOTO, YU ISHIZUYA, TAKUJI HAYASHI, YOSHIYUKI YAMAMOTO, KOJI HATANO, ATSUNARI KAWASHIMA, TETSUYA TAKAO, KENSAKU NISHIMURA, SHINGO TAKADA, MASAO TSUJIHATA and NORIO NONOMURA
    Anticancer Research February 2025, 45 (2) 639-650; DOI: https://doi.org/10.21873/anticanres.17451
  • Open Access
    Clinical Impact of Cellular Senescence and RNA Dysregulation in HCC Is Associated With MASLD and HCV-SVR
    SHOTARO MIYASHITA, TAKAYUKI SHIMIZU, MAIKO NIKI, SHUN SATO, GENKI TANAKA, TAKAMUNE YAMAGUCHI, KWANG HWA PARK, TAKATSUGU MATSUMOTO, TAKAYUKI SHIRAKI, SHOZO MORI and TAKU AOKI
    Anticancer Research February 2025, 45 (2) 651-659; DOI: https://doi.org/10.21873/anticanres.17452
  • You have access
    Use of Indocyanine Green Fluorescence Angiography to Assess Bowel Anastomosis in Ovarian Cancer Surgery
    BEATRIZ NAVARRO SANTANA, OCTAVIO ARENCIBIA, GUILLAUME BABIN, EUDALDO TOMMASETTI, SARA FORTE, ALICIA MARTÍN MARTÍNEZ and FREDERIC GUYON
    Anticancer Research February 2025, 45 (2) 661-666; DOI: https://doi.org/10.21873/anticanres.17453
  • Open Access
    Free Interleukin 18 (IL-18F) Blood Levels Following Midline Laparotomy: A Prospective Randomized Study of Patients With Benign Disease and Patients With Cancer
    MAARET ESKELINEN, TUOMAS SELANDER, JUKKA PULKKINEN, KAI KAARNIRANTA, ESA HÄMÄLÄINEN and MATTI ESKELINEN
    Anticancer Research February 2025, 45 (2) 667-675; DOI: https://doi.org/10.21873/anticanres.17454
  • Open Access
    Prognostic Significance of the Detection of Human Papilloma Virus L1 Protein in Smears of Cervical Intraepithelial Neoplasia Grade 3 in Pregnant Women
    FREDERIK A. STUEBS, ANNA K. DIETL, CARLA E. SCHULMEYER, ANNIKA S. BEHRENS, ANJA SEIBOLD, LENA BRUECKNER, OLIVER SCHLEICHER, WERNER ADLER, CAROL GEPPERT, ARNDT HARTMAN, ANTJE KNÖLL, MATTHIAS W. BECKMANN, PAUL GASS, RALF HILFRICH and GRIT MEHLHORN
    Anticancer Research February 2025, 45 (2) 677-683; DOI: https://doi.org/10.21873/anticanres.17455
  • You have access
    Enhanced Potential of Durvalumab in the Initial Treatment of Advanced Biliary Tract Cancer
    JUNGO YASUDA, HIRONORI SHIOZAKI, TARO SAKAMOTO, YASURO FUTAGAWA, TOMOYOSHI OKAMOTO and TORU IKEGAMI
    Anticancer Research February 2025, 45 (2) 685-690; DOI: https://doi.org/10.21873/anticanres.17456
  • Open Access
    Peak-postoperative Serum Transaminases Correlate With Post-hepatectomy Liver Failure and Inflow Occlusion After Laparoscopic Liver Resection
    HAJIME KAMIYA, TAISUKE IMAMURA, HISASHI IKOMA, RYO MORIMURA, YUSUKE YAMAMOTO, JUN KIUCHI, KENJI NANISHI, HIROKI SHIMIZU, TOMOHIRO ARITA, HIROTAKA KONISHI, ATSUSHI SHIOZAKI, TAKESHI KUBOTA, HITOSHI FUJIWARA and EIGO OTSUJI
    Anticancer Research February 2025, 45 (2) 691-700; DOI: https://doi.org/10.21873/anticanres.17457
  • Open Access
    Bladder Volume <200 ml During a Course of Moderate Hypofractionated Irradiation in Patients With Localized Prostate Cancer
    DIRK RADES, CHARLOTTE KRISTIANSEN, CHRISTINE VESTERGAARD MADSEN, JAN-DIRK KÜTER, LAURA SPLETTSTÖSSER, CATHRIN THIEME, JON CACICEDO and STEFAN JANSSEN
    Anticancer Research February 2025, 45 (2) 701-708; DOI: https://doi.org/10.21873/anticanres.17458
  • You have access
    The Impact of Tonsillectomy on Oropharyngeal Cancer Development
    SHIRRELL GLITZKY, ACHIM FRANZEN and ANNEKATRIN COORDES
    Anticancer Research February 2025, 45 (2) 709-718; DOI: https://doi.org/10.21873/anticanres.17459
  • You have access
    Clinicopathological and Molecular Insights into Primary Retroperitoneal Squamous Cell Carcinoma: HPV Association and Discovery of Recurrent PIK3CA E545K Mutation
    HAN GYEOL KIM, SUNG KYOUNG MOON, HYUN-SOO KIM and KIYONG NA
    Anticancer Research February 2025, 45 (2) 719-731; DOI: https://doi.org/10.21873/anticanres.17460
  • You have access
    Efficacy and Safety of Amrubicin Monotherapy After Chemoradiotherapy in Patients With Relapsed Limited Disease Small-cell Lung Cancer
    AKIRA MATSUKIDA, HISAO IMAI, AYAKO SHIONO, YASUHIRO RYUNO, KOSUKE HASHIMOTO, YU MIURA, SATOSHI ENDO, SHOHEI OKAZAKI, OU YAMAGUCHI, ATSUTO MOURI, TAKANORI ABE, KYOICHI KAIRA, KUNIHIKO KOBAYASHI, SHINGO KATO and HIROSHI KAGAMU
    Anticancer Research February 2025, 45 (2) 733-741; DOI: https://doi.org/10.21873/anticanres.17461
  • You have access
    Negative Impact of Low Serum Cholinesterase on Short- and Long-term Outcomes in Elderly Patients Undergoing Scheduled Surgery for Colorectal Cancer
    TERUYUKI TAKISHIMA, YASUNOBU KOBAYASHI, SAYA MATSUKIDA, WATARU KAI, YASUHIRO TAKANO, HIRONORI KANNO, TOSHIAKI MORIKAWA, NOBUYOSHI HANNYU and KEN ETO
    Anticancer Research February 2025, 45 (2) 743-750; DOI: https://doi.org/10.21873/anticanres.17462
  • You have access
    Prognostic Stratification Using Early Prostate-specific Antigen Kinetics in Men With Metastatic Hormone-sensitive Prostate Cancer
    TASUKU HIROSHIGE, HIROKI SUEKANE, TAKAHO TOKUNAGA, MAMI UEGAKI, MASAHITO IWASHITA, HIROKI TAURA, TAISHI HIRANO, TOMOTARO MITANI, MITSUNORI MATSUO and TSUKASA IGAWA
    Anticancer Research February 2025, 45 (2) 751-759; DOI: https://doi.org/10.21873/anticanres.17463
  • You have access
    Ex Vivo Endocytoscopic Evaluation of Pancreatobiliary Cancers: A Step Toward Real-time In Vivo Diagnosis
    SUGURU SASAMOTO, TAKESHI AOKI, YOSHIHIKO TASHIRO, KAZUHIRO MATSUDA, TATSUYA YAMAZAKI, HIROKI YAMAUE, JUN OHARA, MAYUMI HOMMA, MASAFUMI TAKIMOTO and TOSHIKO YAMOCHI
    Anticancer Research February 2025, 45 (2) 761-771; DOI: https://doi.org/10.21873/anticanres.17464
  • You have access
    Prognostic Significance of Splenic Vein Invasion for Pancreatic Cancer Patients With Pancreatectomy: A Retrospective Study
    RYO SAITO, HIDETAKE AMEMIYA, WATARU IZUMO, YUUKI NAKATA, SUGURU MARUYAMA, KOICHI TAKIGUCHI, KATSUTOSHI SHODA, KENSUKE SHIRAISHI, SHINJI FURUYA, YOSHIHIKO KAWAGUCHI, HIROMICHI KAWAIDA and DAISUKE ICHIKAWA
    Anticancer Research February 2025, 45 (2) 773-779; DOI: https://doi.org/10.21873/anticanres.17465
  • You have access
    Negative Impact of High FOXP3 Status in Lymph Nodes of Esophageal Squamous Cell Carcinoma Patients
    YUKIKO NONAKA, TAISUKE BABA, SHIZUKI SUGITA, KAZUSHI MIYATA, MASAKI SUNAGAWA, JUNPEI YAMAGUCHI, TOSHIO KOKURYO, YUKIHIRO YOKOYAMA and TOMOKI EBATA
    Anticancer Research February 2025, 45 (2) 781-787; DOI: https://doi.org/10.21873/anticanres.17466
  • You have access
    Clinical Utility of Sentinel Lymph Node Biopsy Using the Medical Imaging Projection System in Breast Cancer Patients, Including Those Following Neoadjuvant Chemotherapy
    AOI OSHIRO, MASAYUKI NAGAHASHI, YUSA TOGASHI, HARUKA KANAOKA, AKIRA HATTORI, JUNKO TSUCHIDA, TOMOKO HIGUCHI, ARISA NISHIMUKAI and YASUO MIYOSHI
    Anticancer Research February 2025, 45 (2) 789-796; DOI: https://doi.org/10.21873/anticanres.17467
  • You have access
    Safety and Survival Benefit of Adjuvant Chemotherapy for Elderly Patients With Stage II/III Colon Cancer
    IN JUN YANG, DONG HA KIM, KYUNG-HA LEE and JI YEON KIM
    Anticancer Research February 2025, 45 (2) 797-809; DOI: https://doi.org/10.21873/anticanres.17468
  • You have access
    Up-regulated DDX39 in Adrenocortical Carcinoma Is Associated With Patient Survival
    YOSHIATSU TANAKA, SHIN-NOSUKE YAMASHITA, SHAJEDUL ISLAM, TAKAO KITAGAWA, KAZUHIRO TOKUDA, DURGA PAUDEL, SARITA GIRI, TOHRU OHTA, FUMIYA HARADA, HIROKI NAGAYASU and YASUHIRO KURAMITSU
    Anticancer Research February 2025, 45 (2) 811-815; DOI: https://doi.org/10.21873/anticanres.17469
  • You have access
    Impact of Perioperative Rehabilitation on Postoperative Length of Hospital Stay for Patients With Gastric Cancer
    KEISUKE KOMORI, FUMIYO ABIKO, TAKU ICHIKAWA, KANAKO ANDO, RIKA SHIGEEDA, TOMOHIRO YAMAGUCHI, KEIICHI KURUSU, MASAYUKI ARAI, KAORI MISAWA, SHUJI ANDO, KAZUKI KOYAMA, KOICHIRO SHIMIZU, YUTA NAKAYAMA, YO MIKAYAMA, YOSHIHIRO SUZUKI, YASUSHI RINO and AYA SAITO
    Anticancer Research February 2025, 45 (2) 817-822; DOI: https://doi.org/10.21873/anticanres.17470

Corrigenda

  • Open Access
    Corrigenda
    Anticancer Research February 2025, 45 (2) 823; DOI: https://doi.org/10.21873/anticanres.17471
Back to top
PreviousNext

In this issue

Anticancer Research: 45 (2)
Anticancer Research
Vol. 45, Issue 2
February 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Noncancerous Exosomes Establish a Growth Promoting Paracrine Effect on Triple Negative Breast Cancer Cells
  • Acyclic Retinoid Inhibits the EGFR/AKT Signaling Pathway and Cancels Cisplatin-resistant Cell Characteristics
  • Unusual Presentation of Advanced Urothelial Cancer in a Young Patient
  • Clinical Impact of Cellular Senescence and RNA Dysregulation in HCC Is Associated With MASLD and HCV-SVR
  • Efficacy of Second-line Nivolumab Versus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma With Bone Metastases
Sign up for alerts

Jump to

  • Review
  • Experimental Studies
  • Clinical Studies
  • Corrigenda
  • Top Topics
  • Most Cited
  • Most Read
Loading
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire